Multicentric, Open Label With Retrospective Inclusion and Follow-up of Acetabular Prothetic Implant "Polymax"

NCT ID: NCT02826187

Last Updated: 2024-06-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

181 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-07-31

Study Completion Date

2022-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Total replacement of hip joint is one of the most important medical innovations of the twentieth century. More than 100,000 hip replacements are being laid each year in France.

Improved fixation, reduced wear rates and reduced implant dislocation rates remain subjects of continuous improvement.

Hip implants cemented and cementless are part of therapeutic arsenal of orthopedic surgeons for joint replacement of the defective hip.

The anchor and friction torque are both essential to the survival of hip implants. Therefore acetabular implants without cement with ceramic insert or polyethylene in a metalback or full polyethylene coated with titanium grains without metalback are proposed, but they have their own complications (Squeaking, fractures, recovery difficulties, difficult radiographic analysis, high cost for ceramics, primary stability defects, instability of the instrument set, Titanium residues in absence of metalback. An alternative to these implants may be an acetabular component without cement with polyethylene insert with an end metalback to increase both polyethylene thickness and size of the head in order to expect a low complication rate with important longevity for a lower cost.

This study was conducted to ensure the safety and effectiveness of the acetabular implant "POLYMAX"

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoarthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with acetabular implant

Data to be collected are :

* Early complications data related to implant or procedure of implantation
* Late stage complications data
* Efficacity of treatment with HIP score
* Patient satisfaction
* Radiographic evaluation during standard follow-up

Early complications data

Intervention Type OTHER

Early complications of interest are :

* New arthroplasty for any reason
* Related to the implant :

* Wrong position of the implant
* Early displacement of the implant
* Related to the intervention :

* Hematoma
* Dislocation (or not causing the resumption of joint replacement)
* Deep vein thrombosis
* Pulmonary embolism
* Acute Infection

Late stage complications data

Intervention Type OTHER

Late complications taken into account are:

* New arthroplasty for any reason
* Aseptic loosening
* Delayed hypersensitivity reaction type IV
* Solid Tumors
* Recurrent dislocation (causing or not the resumption of joint replacement)
* Allergic reactions of any kind
* Chronic infection

Patient Satisfaction

Intervention Type OTHER

Patient satisfaction evaluated by Womac reduced Score

Efficacity

Intervention Type OTHER

Efficacity as evaluated by Harris HIP score

Radiographic evaluation

Intervention Type OTHER

Bone reaction visible in radiography

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Early complications data

Early complications of interest are :

* New arthroplasty for any reason
* Related to the implant :

* Wrong position of the implant
* Early displacement of the implant
* Related to the intervention :

* Hematoma
* Dislocation (or not causing the resumption of joint replacement)
* Deep vein thrombosis
* Pulmonary embolism
* Acute Infection

Intervention Type OTHER

Late stage complications data

Late complications taken into account are:

* New arthroplasty for any reason
* Aseptic loosening
* Delayed hypersensitivity reaction type IV
* Solid Tumors
* Recurrent dislocation (causing or not the resumption of joint replacement)
* Allergic reactions of any kind
* Chronic infection

Intervention Type OTHER

Patient Satisfaction

Patient satisfaction evaluated by Womac reduced Score

Intervention Type OTHER

Efficacity

Efficacity as evaluated by Harris HIP score

Intervention Type OTHER

Radiographic evaluation

Bone reaction visible in radiography

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient suffering from hip disease: primary or secondary hip osteoarthritis or osteonecrosis.
* Patient having been implanted with a POLYMAX implant;
* Patient having agreed to participate in a follow-up 5 years;
* Patient who have accepted the use of their data in the context of this study.
* Patient having pre-operative and post-operative data

Exclusion Criteria

* Pre or post-operative Partial data
* Patients not available for follow up at 2 and 5 years ..
* Metabolic disease or autoimmune witch may interfere with bone growth not allowing the indication of a prosthesis without cement,
* Mental disorder or disease of proven behavior.
* Severe osteoporosis,
* Direct or indirect bone irradiation
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Toulouse

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Philippe CHIRON, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital of Toulouse

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Saint Grégoire Hospital

Saint-Grégoire, , France

Site Status

Purpan Hospital

Toulouse, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RC31/15/7859

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Exception Cementless Hip Stem
NCT04349046 ACTIVE_NOT_RECRUITING